We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
+10.51%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
AUM
$1.21B
AUM Growth
+$355M
Cap. Flow
+$316M
Cap. Flow %
26.21%
Top 10 Hldgs %
40.06%
Holding
747
New
182
Increased
169
Reduced
181
Closed
163

Sector Composition

Rank Sector Weight
1 Healthcare 36.03%
2 Financials 28.77%
3 Technology 9.99%
4 Energy 5.75%
5 Consumer Discretionary 4.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WAVC
76
DELISTED
Waverley Capital Acquisition Corp. 1
WAVC
$3.13M 0.26%
+301,784
New +$3.1M
MUFG icon
77
Mitsubishi UFJ Financial
MUFG
$250B
$3.02M 0.25%
+410,000
New +$2.73M
LCW
78
DELISTED
Learn CW Investment Corporation Class A Ordinary Shares
LCW
$2.9M 0.24%
+277,073
New +$2.88M
OKLO
79
Oklo
OKLO
$7.76B
$2.85M 0.24%
+273,351
New +$2.85M
FRXB
80
DELISTED
Forest Road Acquisition Corp. II
FRXB
$2.75M 0.23%
+268,766
New +$2.71M
BREZ
81
DELISTED
Breeze Holdings Acquisition Corp. Common Stock
BREZ
$2.7M 0.22%
250,000
TARO
82
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
$2.68M 0.22%
70,606
AILE
83
DELISTED
iLearningEngines, Inc. Common Stock
AILE
$2.66M 0.22%
255,180
+35,179
+16% +$364K
TWCB
84
DELISTED
Bilander Acquisition Corp. Class A Common Stock
TWCB
$2.54M 0.21%
+249,900
New +$2.53M
AFTR
85
DELISTED
AfterNext HealthTech Acquisition Corp
AFTR
$2.46M 0.2%
237,180
+189,980
+403% +$1.96M
XGN icon
86
Exagen
XGN
$161M
$2.44M 0.2%
842,376
-101,176
-11% -$288K
ACI icon
87
Albertsons Companies
ACI
$5.87B
$2.4M 0.2%
110,000
+10,000
+10% +$208K
BTWN
88
DELISTED
Bridgetown Holdings Limited Class A Ordinary Shares
BTWN
$2.38M 0.2%
+232,132
New +$2.35M
HHLA
89
DELISTED
HH&L Acquisition Co.
HHLA
$2.36M 0.2%
225,000
NFNT
90
DELISTED
Infinite Acquisition Corp.
NFNT
$2.34M 0.19%
+221,260
New +$2.32M
GPP
91
DELISTED
Green Plains Partners LP
GPP
$2.25M 0.19%
+173,916
New +$2.22M
NMR icon
92
Nomura Holdings
NMR
$28.7B
$2.18M 0.18%
+570,000
New +$2.11M
ROSS
93
DELISTED
Ross Acquisition Corp II
ROSS
$2.18M 0.18%
+206,040
New +$2.14M
SDST
94
Stardust Power Inc
SDST
$7.24M
$2.18M 0.18%
20,537
+537
+3% +$56.3K
CNGL
95
DELISTED
Canna-Global Acquisition Corp. Class A Common Stock
CNGL
$2.15M 0.18%
200,000
ACRO
96
DELISTED
Acropolis Infrastructure Acquisition Corp
ACRO
$2.13M 0.18%
+210,227
New +$2.14M
AFAR
97
DELISTED
Aura FAT Projects Acquisition Corp Class A Ordinary Shares
AFAR
$2.12M 0.18%
+200,111
New +$2.11M
QFTA
98
DELISTED
Quantum FinTech Acquisition Corporation
QFTA
$2.12M 0.18%
203,711
+3,711
+2% +$38.3K
ZING
99
DELISTED
FTAC Zeus Acquisition Corp. Class A Common Stock
ZING
$2.1M 0.17%
201,623
+132,987
+194% +$1.38M
PUCK
100
DELISTED
Goal Acquisitions Corp. Common Stock
PUCK
$2.1M 0.17%
201,887
+91,870
+84% +$944K

Similar funds

Cowen and Company's Q2 2023 Portfolio in Review

As of Q2 2023, Cowen and Company held 747 positions worth $1.21B, up 42% from $851M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Cowen and Company deployed $316M of net new capital in Q2 2023, opening 182 new positions and adding to 169 existing holdings. Its largest new stake was NVIDIA: 1,927,500 shares worth $81.5M.

By sector, the portfolio is most concentrated in Healthcare at 36% of assets, down from 38% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Avadel Pharmaceuticals, an estimated $13.9M trimmed.

  • Cowen and Company's largest Q2 2023 buy was NVIDIA: 1,927,500 shares worth $81.5M.
  • Cowen and Company added most to Ares Acquisition Corporation in Q2 2023, an estimated $15.9M increase.
  • Cowen and Company's biggest Q2 2023 reduction was Avadel Pharmaceuticals, cutting an estimated $13.9M.
  • Cowen and Company fully exited Sylvamo in Q2 2023, selling an estimated $99.5M.
  • Cowen and Company's ten largest holdings make up 40% of its $1.21B portfolio in Q2 2023.
  • Cowen and Company opened 182 new positions and closed 163 in Q2 2023.
  • Cowen and Company's portfolio value rose 42% quarter-over-quarter to $1.21B.

Based on Cowen and Company's 13F filing for Q2 2023, filed 7 Aug 2023.